Showing 5251-5260 of 21466 results for "".
- Long-Term HBV DNA Response Patterns Track Outcomes In Cirrhosishttps://reachmd.com/news/hbv-dna-patterns-cirrhosis/2487176/Key Takeaways HBV DNA response patterns during the first two years of nucleos(t)ide analog therapy identified distinct long-term outcome groups in patients with HBV-related cirrhosis. Patients with maintained virological response had lower hepatocellul
- Evaluating an Antibiotic Stewardship for Sore Throat in Primary Carehttps://reachmd.com/news/stewardship-sore-throat-primary-care/2487175/Key Takeaways A 6-month antimicrobial stewardship program for acute sore throat combined guideline-reflection meetings, didactic case discussions, local quality improvement work, and repeated audit and feedback using laboratory and prescribing data. Lo
- UC Trial Tests Non-Opioid Relief For Severe Post-Stroke Headacheshttps://reachmd.com/news/uc-trial-tests-non-opioid-relief-for-severe-post-stroke-headaches/2487180/Key Takeaways BLOCK-SAH is enrolling patients recovering from SAH to compare ropivacaine plus dexamethasone injection with saline placebo. The primary objective is opioid use within 24 hours, with additional assessment of pain intensity, tolerability,
- Cerebral Oxygenation-Guided Resuscitation and MRI Outcomes In Preterm Neonateshttps://reachmd.com/news/cosgod-mri-preterm-neonates/2487174/Key Takeaways In preterm infants, MRI-defined brain injury incidence did not differ between NIRS-guided and control groups. The NIRS group showed a larger biparietal diameter, with a reported trend toward fewer abnormal biparietal diameter findings.
- Host-Response Optimization Trial After Ultra-Low Anterior Resectionhttps://reachmd.com/news/host-response-optimization-trial-after-ultra-low-anterior-resection/2487160/Key Takeaways Twenty-four-month disease-free survival and overall survival were both higher in the intervention group than in the standard ERAS group. Functional recovery was better with the integrated program across bowel, sleep, psychological, and se
- Four-Year RHONE-X Data Show Durable Faricimab Outcomes in DMEhttps://reachmd.com/news/four-year-rhone-x-data-show-durable-faricimab-outcomes-in-dme/2487161/Key Takeaways Visual acuity gains of about 10 to 11 letters were maintained, alongside sustained CST reductions and DME absence by study definition (CST < 325 μm) in more than 90% of patients at study end. About 80% of patients reached intervals of
- Esketamine-Led Opioid-Free Anaesthesia Lowers PPCs in Bariatric Surgeryhttps://reachmd.com/news/esketamine-led-opioid-free-anaesthesia-lowers-ppcs-in-bariatric-surgery/2487151/Key Takeaways Esketamine-led opioid-free anesthesia was associated with lower postoperative pulmonary complication rates and lower hypoxemia incidence in this randomized bariatric surgery trial. Twenty-four-hour opioid consumption was lower while posto
- External Validation of Deep Learning for Dysplastic Barrett's Esophagushttps://reachmd.com/news/external-validation-of-deep-learning-for-dysplastic-barretts-esophagus/2487156/Key Takeaways External validation of a previously cross-validated Barrett's esophagus dysplasia model used 489 whole-slide images from three academic centers. Sensitivity and specificity varied across nondysplastic Barrett's esophagus, low-grade dyspla
- Foot Core Training Plus Hip And Knee Strengthening For Patellofemoral Painhttps://reachmd.com/news/foot-core-training-plus-hip-and-knee-strengthening-for-patellofemoral-pain/2487163/Key Takeaways Adding foot-core training to hip–knee strengthening was associated with greater post-intervention pain reduction and higher function scores than hip–knee strengthening alone. The experimental group showed lower hip adduction and knee valg
- Ensitrelvir Versus Nirmatrelvir in COVID-19 Viral Clearancehttps://reachmd.com/news/ensitrelvir-versus-nirmatrelvir-in-covid-19-viral-clearance/2487153/Key Takeaways Both 5-day oral antiviral regimens were associated with faster oropharyngeal SARS-CoV-2 clearance than no study drug, and nirmatrelvir showed the faster signal head to head. The trial enrolled low-risk adult outpatients early in illness a